|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bornschein J, Selgrad M, Warnecke M,
Kuester D, Wex T and Malfertheiner P: H. pylori infection is a key
risk factor for proximal gastric cancer. Dig Dis Sci. 55:3124–3131.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang L, Yang KH, Guan QL, Zhao P, Chen Y
and Tian JH: Survival and recurrence free benefits with different
lymphadenectomy for resectable gastric cancer: A meta-analysis. J
Surg Oncol. 107:807–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tao L, Huang G, Song H, Chen Y and Chen L:
Cancer associated fibroblasts: An essential role in the tumor
microenvironment. Oncol Lett. 14:2611–2620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shiga K, Hara M, Nagasaki T, Sato T,
Takahashi H and Takeyama H: Cancer-associated fibroblasts: Their
characteristics and their roles in tumor growth. Cancers.
7:2443–2458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chung HW and Lim JB: Role of the tumor
microenvironment in the pathogenesis of gastric carcinoma. World J
Gastroenterol. 20:1667–1680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier
C and Brown RA: Myofibroblasts and mechano-regulation of connective
tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marsh T, Pietras K and McAllister SS:
Fibroblasts as architects of cancer pathogenesis. Biochim Biophys
Acta. 1832:1070–1078. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ostman A and Augsten M: Cancer-associated
fibroblasts and tumor growth-bystanders turning into key players.
Curr Opin Genet Dev. 19:67–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Öhlund D, Elyada E and Tuveson D:
Fibroblast heterogeneity in the cancer wound. J Exp Med.
211:1503–1523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan Y, Wang LF and Wang RF: Role of
cancer-associated fibroblasts in invasion and metastasis of gastric
cancer. World J Gastroenterol. 21:9717–9726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pang T, Wang X, Gao J, Chen W, Shen XJ,
Nie MM, Luo T, Yin K, Fang G, Wang KX, et al: Fiber-modified
hexon-chimeric oncolytic adenovirus targeting cancer associated
fibroblasts inhibits tumor growth in gastric carcinoma. Oncotarget.
8:76468–76478. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gotlieb WH, Saumet J, Beauchamp MC, Gu J,
Lau S, Pollak MN and Bruchim I: In vitro metformin anti-neoplastic
activity in epithelial ovarian cancer. Gynecol Oncol. 110:246–250.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akinyeke T, Matsumura S, Wang X, Wu Y,
Schalfer ED, Saxena A, Yan W, Logan SK and Li X: Metformin targets
c-MYC oncogene to prevent prostate cancer. Carcinogenesis.
34:2823–2832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zakikhani M, Dowling R, Fantus IG,
Sonenberg N and Pollak M: Metformin is an AMP kinase-dependent
growth inhibitor for breast cancer cells. Cancer Res.
66:10269–10273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu C, Jiao Y, Xue J, Zhang Q, Yang H, Xing
L, Chen G, Wu J, Zhang S, Zhu W and Cao J: Metformin sensitizes
non-small cell lung cancer cells to an epigallocatechin-3-gallate
(EGCG) treatment by suppressing the Nrf2/HO-1 signaling pathway.
Int J Biol Sci. 13:1560–1569. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Safe S, Naira V and Karki K:
Metformin-induced anticancer activities: Recent insights.
Metformin-induced anticancer activities: Recent insights. Biol
Chem. 399:321–335. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malki A and Youssef A: Antidiabetic drug
metformin induces apoptosis in human MCF breast cancer via
targeting ERK signaling. Oncol Res. 19:275–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhalla K, Hwang BJ, Dewi RE, Twaddel W,
Goloubeva OG, Wong KK, Saxena NK, Biswal S and Girnun GD: Metformin
prevents liver tumorigenesis by inhibiting pathways driving hepatic
lipogenesis. Cancer Prev Res (Philla). 5:544–552. 2012. View Article : Google Scholar
|
|
26
|
Chen G, Feng W, Zhang S, Bian K, Yang Y,
Fang C, Chen M, Yang J and Zou X: Metformin inhibits gastric cancer
via the inhibition of HIF1α/PKM2 signaling. Am J Cancer Res.
5:1423–1434. 2015.PubMed/NCBI
|
|
27
|
Yang B, Li M, Tang W, Liu W, Zhang S, Chen
L and Xia J: Dynamic network biomarker indicates pulmonary
metastasis at the tipping point of hepatocellular carcinoma. Nat
Commun. 9:6782018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang X, Xu X, Zhu J, Zhang S, Wu Y, Wu Y,
Zhao K, Xing C, Cao J, Zhu H, et al: miR-31 affects colorectal
cancer cells by inhibiting autophagy in cancer-associated
fibroblasts. Oncotarget. 7:79617–79628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu J, Dong X, Wang L, Ji H and Liu A:
Antitumor effects of seleno-β-lactoglobulin (Se-β-Lg) against human
gastric cancer MGC-803 cells. Eur J Pharmacol. 833:109–115. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Olumi AF, Grossfeld GD, Hayward SW,
Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts
direct tumor progression of initiated human prostatic epithelium.
Cancer Res. 59:5002–5011. 1999.PubMed/NCBI
|
|
31
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Klil-Drori AJ, Azoulay L and Pollak MN:
Cancer, obesity, diabetes, and antidiabetic drugs: Is the fog
clearing? Nat Rev Clin Oncol. 14:85–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vermeulen L, De Sousa E, Melo F, van der
Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M,
Merz C, Rodermond H, et al: Wnt activity defines colon cancer stem
cells and is regulated by the microenvironment. Nat Cell Biol.
12:468–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Borges FT, Melo SA, Özdemir BC, Kato N,
Revuelta I, Miller CA, Gattone VH II, LeBleu VS and Kalluri R:
TGF-β1-containing exosomes from injured epithelial cells activate
fibroblasts to initiate tissue regenerative responses and fibrosis.
J Am Soc Nephrol. 24:385–392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kahlert C and Kalluri R: Exosomes in tumor
microenvironment influence cancer progression and metastasis. J Mol
Med. 91:431–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luga V and Wrana JL: Tumor-stroma
interaction: Revealing fibroblast-secreted exosomes as potent
regulators of Wnt-planar cell polarity signaling in cancer
metastasis. Cancer Res. 73:6843–6847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yaswen P, Smoll A, Peehl DM, Trask DK,
Sager R and Stampfer MR: Down-regulation of a calmodulin-related
gene during transformation of human mammary epithelial cells. Proc
Natl Acad Sci USA. 87:7360–7364. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rogers MS, Foley MA, Crotty TB, Hartmann
LC, Ingle JN, Roche PC and Strehler EE: Loss of immunoreactivity
for human calmodulin-like protein is an early event in breast
cancer development. Neoplasia. 1:220–225. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brooks MD, Bennett RD, Strehler EE, Sebo
TJ, Eckert SE and Carr AB: Human calmodulin-like protein (CLP)
expression in oral squamous mucosa and in malignant transformation.
J Prosthodont. 18:11–16. 2009. View Article : Google Scholar : PubMed/NCBI
|
